Goldman Sachs Group »

Oramed Pharm shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 253k 4.81
2023-09-30 $401k 154k 2.61
2023-06-30 $326k 91k 3.58
2023-03-31 $220k 101k 2.18
2022-12-31 $199k 17k 12.03
2022-06-30 $130k 28k 4.58
2022-03-31 $608k 70k 8.66
2021-12-31 $1.7M 117k 14.28
2021-09-30 $435k 20k 22.01
2021-03-31 $201k 20k 10.17